Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid dosing in total knee arthroplasty
ACTRN12621001327875Phase 4Completed
- Sponsor
- Wesley Research Institute
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tranexamic acid in perioperative hemorrhage (2 arms), sponsored by Wesley Research Institute. Primary endpoint: Blood loss. Started Jan 2022; status: completed.
02
Drugs
tranexamic acid
03
Conditions
perioperative hemorrhage
Beyond the preview
Go deeper on ACTRN12621001327875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001327875.